Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Can-Fite BioPharma Ltd. (CANF)

1.24 -0.04 (-3.12%)

06-22 16:00

Open:

1.28

Pre. Close:

1.28

High:

1.28

Low:

1.24

Volume:

170,490

Market Cap:

27M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.281 - 1.292

1.292 - 1.299

Low:

1.228 - 1.24

1.24 - 1.248

Close:

1.245 - 1.263

1.263 - 1.275

Technical analysis  (as of: 2018-06-22 4:29:00 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 1.65     One year: 1.81

Support:

Support1: 1.18    Support2: 0.98

Resistance:

Resistance1: 1.41    Resistance2: 1.55

Pivot:

1.29

Moving Averages:

MA(5): 1.29     MA(20): 1.29

MA(100): 1.53     MA(250): 1.61

MACD:

MACD(12,26): -0.01     Signal(12,26,9): -0.01

%K %D:

%K(14,3): 29.73     %D(3): 32.43

RSI:

RSI(14): 45.11

52-Week:

High: 2.75  Low: 1.18  Change(%): -30.0

Average Vol(K):

3-Month: 21161  10-Days 103213

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
CANF has closed above bottom band by 26.6%. Bollinger Bands are 61.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to CANF's normal range. The bands have been in this narrow range for 59 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-06-21T08:00:00-04:00
Your Daily Pharma Scoop: Anika Fails Trial, Kala's Upcoming Catalyst, Sarepta Surges

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  0

Industry:  0

Shares Out. (M)

19.98

Shares Float (M)

19.98

% Held by Insiders

% Held by Institutions

5.60

Shares Short (K)

117

Shares Short Prior Month (K)

115

Stock Financials

EPS

-0.320

EPS Est. Current Year

-0.270

EPS Est. Next Year

-0.610

EPS Est. Next Quarter

-0.080

Forward EPS

-0.460

Book Value (p.s.)

3.520

PEG Ratio

Profit Margin

Operating Margin

-873.13

Return on Assets (ttm)

-37.3

Return on Equity (ttm)

-70.3

Qtrly Rev. Growth

3511.1

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.121

Qtrly Earnings Growth

Operating Cash Flow (M)

-9.37

Levered Free Cash Flow (M)

-6.12

atoplab.com

Valuation

P/E

-3.94

P/E Growth Ratio

-0.02

P/BV

0.36

P/S

875196032.00

P/CF

-2.69

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.